| scholarly article | Q13442814 |
| P50 | author | Zheng Yin | Q56705873 |
| Dale J. Hamilton | Q61785100 | ||
| Christopher B Newgard | Q87867408 | ||
| Stephen T C Wong | Q92223498 | ||
| Guillermo Torre-Amione | Q99344173 | ||
| Matthias Loebe | Q114312358 | ||
| Leif E. Peterson | Q38802574 | ||
| Anisha A. Gupte | Q39829946 | ||
| P2093 | author name string | Willa A Hsueh | |
| Heinrich Taegtmeyer | |||
| Olga Ilkayeva | |||
| Andrea M Cordero-Reyes | |||
| Jerry D Estep | |||
| Keith A Youker | |||
| Christopher J Lyon | |||
| Robert D Stevens | |||
| Brett Wenner | |||
| P2860 | cites work | Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance | Q40028148 |
| Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study | Q40251749 | ||
| p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice | Q41673217 | ||
| Utilization of energy-providing substrates in the isolated working rat heart | Q41867995 | ||
| Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling | Q43032221 | ||
| Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II. | Q43266258 | ||
| Metabolic gene expression in fetal and failing human heart | Q43819742 | ||
| Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. | Q44014981 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| Advanced heart failure treated with continuous-flow left ventricular assist device | Q48952442 | ||
| ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. | Q51579173 | ||
| The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. | Q55044173 | ||
| p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload | Q57396501 | ||
| Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate | Q67779190 | ||
| Glutamic dehydrogenase from rat heart mitochondria. II. Kinetic characteristics | Q71362742 | ||
| Conditions for glutamate dehydrogenase activity in heart mitochondria | Q72927222 | ||
| Proteomic profiling of the human failing heart after left ventricular assist device support | Q83144586 | ||
| Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study | Q83224125 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans | Q27931310 | ||
| Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading | Q28216246 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| The failing heart--an engine out of fuel | Q29617881 | ||
| Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. | Q30483132 | ||
| Telomere biology in healthy aging and disease | Q33572237 | ||
| Defective DNA replication impairs mitochondrial biogenesis in human failing hearts | Q33892073 | ||
| Telomere dysfunction induces metabolic and mitochondrial compromise. | Q34163637 | ||
| Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate | Q34179908 | ||
| Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation | Q34446515 | ||
| The PGC-1 cascade as a therapeutic target for heart failure | Q34587748 | ||
| PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy | Q35218804 | ||
| Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease | Q35556097 | ||
| Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy | Q35580891 | ||
| Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects | Q36065639 | ||
| Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support | Q36125213 | ||
| Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart | Q36605039 | ||
| The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis | Q36807931 | ||
| Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. | Q37021783 | ||
| PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart | Q37189947 | ||
| Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. | Q37374980 | ||
| Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices | Q38008287 | ||
| Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). | Q38442681 | ||
| P433 | issue | 3 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 266-276 | |
| P577 | publication date | 2014-05-13 | |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | Mechanical unloading promotes myocardial energy recovery in human heart failure | |
| P478 | volume | 7 |
| Q92030450 | Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy |
| Q52725359 | Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression. |
| Q39133516 | Cardiac nuclear receptors: architects of mitochondrial structure and function |
| Q52560349 | Cardiovascular Metabolomics. |
| Q41644090 | Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis |
| Q49022015 | Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure |
| Q36246354 | Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure |
| Q35069561 | Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes. |
| Q35165143 | Estrogen-related receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function |
| Q36654675 | Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. |
| Q33651722 | Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning |
| Q38261514 | Hold or fold--proteins in advanced heart failure and myocardial recovery |
| Q29300198 | Human Ventricular Unloading Induces Cardiomyocyte Proliferation |
| Q98830214 | Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients |
| Q55341036 | Loss of Metabolic Flexibility in the Failing Heart. |
| Q56964530 | Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts |
| Q39245449 | Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options. |
| Q88779937 | Metabolic remodeling of substrate utilization during heart failure progression |
| Q39395331 | Metabolic remodelling in hypertrophied and failing myocardium: a review. |
| Q88169588 | Mitochondrial Function in Non-ischemic Heart Failure |
| Q26782031 | Mitochondrial biogenesis and dynamics in the developing and diseased heart |
| Q37091906 | Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). |
| Q38864091 | Myocardial recovery with mechanical circulatory support |
| Q37743798 | Pet Imaging and its Application in Cardiovascular Diseases |
| Q28078529 | Rat Heterotopic Heart Transplantation Model to Investigate Unloading-Induced Myocardial Remodeling |
| Q38265521 | Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart |
Search more.